Remicade infliximab regulatory update

Mitsubishi Tanabe Pharma Corp. (Tokyo:4508, Osaka, Japan) filed an sNDA in Japan for Remicade infliximab to include treatment of neuro-Behcet's disease, entero-Behcet's disease and vasculo-Behcet's d...